35 results on '"Gebregiworgis, Teklab"'
Search Results
2. Author Correction: Cancer-associated fibroblast-derived acetate promotes pancreatic cancer development by altering polyamine metabolism via the ACSS2–SP1–SAT1 axis
3. Alkaline subcritical water extraction of bioactive compounds and antioxidants from beach-cast brown algae (Ascophyllum Nodosum)
4. Crystal structure of NRAS Q61K with a ligand-induced pocket near switch II
5. Lung Cancer Driven by BRAFG469V Mutation Is Targetable by EGFR Kinase Inhibitors
6. NMR in integrated biophysical drug discovery for RAS: past, present, and future
7. The Q61H mutation decouples KRAS from upstream regulation and renders cancer cells resistant to SHP2 inhibitors
8. Tyrosyl phosphorylation of KRAS stalls GTPase cycle via alteration of switch I and II conformation
9. Real-Time NMR
10. Insights into gemcitabine resistance and the potential for therapeutic monitoring
11. Abstract 670: Distinct biochemical properties of KRAS Q61H mutant render cancer cells resistant to SHP2 inhibitors
12. Structures of RGL1 RAS-Association Domain in Complex with KRAS and the Oncogenic G12V Mutant
13. MUC1 mucin stabilizes and activates hypoxia-inducible factor 1 alpha to regulate metabolism in pancreatic cancer
14. Regulation of GTPase function by autophosphorylation
15. MO14-2 KRAS Q61H mutation evades the regulation of tyrosyl phosphorylation and renders cancer cells resistant to SHP2 inhibitor
16. Regulation of GTPase function by autophosphorylation
17. Oncogenic KRAS G12D mutation promotes dimerization through a second, phosphatidylserine–dependent interface: a model for KRAS oligomerization
18. Lung Cancer Driven by BRAFG469V Mutation Is Targetable by EGFR Kinase Inhibitors.
19. Abstract A04: Biophysical and biochemical characterization of Src-phosphorylated KRas
20. Calmodulin disrupts plasma membrane localization of farnesylated KRAS4b by sequestering its lipid moiety
21. Abstract 4360: Altering the regulation of KRAS GTPase cycle via Src and SHP2 creates a potential therapeutic vulnerability for pancreatic cancer
22. 833 - Tyrosyl Phosphorylation of Kras Disrupts the Gtpase Cycle and Inhibits Pancreatic Cancer Cell Growth
23. Multiplexed Real-Time NMR GTPase Assay for Simultaneous Monitoring of Multiple Guanine Nucleotide Exchange Factor Activities from Human Cancer Cells and Organoids
24. MUC1 and HIF-1alpha Signaling Crosstalk Induces Anabolic Glucose Metabolism to Impart Gemcitabine Resistance to Pancreatic Cancer
25. Glucose Limitation Alters Glutamine Metabolism in MUC1-Overexpressing Pancreatic Cancer Cells
26. A Urinary Metabolic Signature for Multiple Sclerosis and Neuromyelitis Optica
27. Application of NMR metabolomics for human disease
28. Erratum to: Metabolic reprogramming induced by ketone bodies diminishes pancreatic cancer cachexia
29. Metabolic reprogramming induced by ketone bodies diminishes pancreatic cancer cachexia
30. Faculty Opinions recommendation of Gut microbiota regulates bile acid metabolism by reducing the levels of tauro-beta-muricholic acid, a naturally occurring FXR antagonist.
31. Abstract 5391: MUC1 and HIF-1α signaling interactions modulate glucose flux in pancreatic cancer.
32. Potential of Urinary Metabolites for Diagnosing Multiple Sclerosis
33. Application of NMR Metabolomics to Search for Human Disease Biomarkers
34. Abstract 5152: Targeting HIF1α-mediated metabolic alterations in pancreatic cancer
35. Lung Cancer Driven by BRAFG469VMutation Is Targetable by EGFR Kinase Inhibitors
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.